Matrix metalloproteinase-degraded type I collagen is associated with APOE/TOMM40 variants and preclinical dementia
Research output: Contribution to journal › Journal article › Research › peer-review
Documents
- e508.full
Final published version, 789 KB, PDF document
Objective
Dysregulation of type I collagen metabolism has a great impact on human health. We have previously seen that matrix metalloproteinase-degraded type I collagen (C1M) is associated with early death and age-related pathologies. To dissect the biological impact of type I collagen dysregulation, we have performed a genome-wide screening of the genetic factors related to type I collagen turnover.
Methods
Patient registry data and genotypes have been collected for a total of 4,981 Danish postmenopausal women. Genome-wide association with serum levels of C1M was assessed and phenotype-genotype association analysis performed.
Results
Twenty-two genome-wide significant variants associated with C1M were identified in the APOE-C1/TOMM40 gene cluster. The APOE-C1/TOMM40 gene cluster is associated with hyperlipidemia and cognitive disorders, and we further found that C1M levels correlated with tau degradation markers and were decreased in women with preclinical cognitive impairment.
Conclusions
Our study provides elements for better understanding the role of the collagen metabolism in the onset of cognitive impairment.
Original language | English |
---|---|
Article number | 508 |
Journal | Neurology: Genetics |
Volume | 6 |
Issue number | 5 |
Number of pages | 9 |
ISSN | 2376-7839 |
DOIs | |
Publication status | Published - 2020 |
- EXTRACELLULAR-MATRIX, APOLIPOPROTEIN-E, IMMUNE-SYSTEM, RISK-FACTOR, DEGRADATION, PROGRESSION, FIBROSIS, BIOMARKERS, FRAGMENTS, MARKER
Research areas
ID: 271502628